Novel <scp>N</scp>rf2 activators from microbial transformation products inhibit blood–retinal barrier permeability in rabbits

Abstract

Nrf2 activators are applicable for treating ocular diseases and novel Nrf2 activators have potential as a unique method for prevention and treatment of retinovascular disease.